In 2023, the market size value per capita of Penicillins and Streptomycins in Brazil stood at approximately $2.01. From 2024 onwards, the forecast data suggests a slight upward trend: both 2024 and 2025 values remain constant at $2.02, followed by a minor increase in 2026 and 2027 at $2.03, eventually reaching $2.04 in 2028. This represents an incremental year-on-year growth of around 0.5% to 0.6% annually.

Future trends to watch for include:

Potential impacts of regulatory changes on pharmaceutical pricing.
Improvements or challenges in healthcare access potentially influencing demand.
Emerging antibiotic resistance trends that could affect the overall usage of these antibiotics.
Technological advancements in drug development and distribution.